PhilipADyMD

Oncology • Effingham, IL

Physician

Join to view full profile

Dr. Dy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dy's full profile

Already have an account?

Office
905 Medical Park Dr
Effingham, IL 62401
Phone+1 217-342-2066

Fax+1 217-342-2074

Education & Training

Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 1995 - 1998
Harlem Hospital CenterResidency, Internal Medicine, 1991 - 1995
University of Santo TomasClass of 1989

Certifications & Licensure

IL State Medical License 1998 - 2026
PA State Medical License 1995 - 1998

Publications & Presentations

PubMed

5 citations
A randomized trial of fulvestrant, everolimus and anastrozole for the front-line treatment of patients with advanced hormone receptor-positive breast cancer, SWOG S1222.
Halle C. F. Moore, William E. Barlow, George Somlo, Julie R. Gralow, Anne F. Schott
Clinical Cancer Research. 2021-11-29
15 citations
A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408.
Andrew M. Evens, Fangxin Hong, Thomas M. Habermann, Ranjana H. Advani, Randy D. Gascoyne
Clinical Cancer Research. 2020-01-01
28 citations
Phase II studies of two different schedules of dasatinib in ***bone metastasis predominant metastatic breast cancer: SWOG S0622
Anne F. Schott, William E. Barlow, Catherine Van Poznak, Daniel F. Hayes, Carol M. Moinpour
Breast Cancer Research and Treatment. 2016-07-30

Press Mentions

OVP’s Bayanihan E-konsulta Notes Surge in COVID-19 Calls; VP on Graveyard ShiftAugust 22nd, 2021